Despite Graves’ disease and Graves’ orbitopathy affecting around 3 million Europeans and costing billions of euros, treatments can only control symptoms. INDIGO identified risk factors, studied microbiota composition and tested probiotics to improve health outcomes. Credit: Perception7, Shutterstock Graves’ disease (GD)—the commonest cause of an overactive thyroid gland—is a chronic autoimmune condition characterized by the...